
News|Videos|August 11, 2023
Advanced Prostate Cancer Therapy: Challenges With Prior Authorization and Reimbursement
A more focused discussion on the specific challenges physicians or patients may face when seeking coverage or reimbursement for GnRH agonists/antagonists in prostate cancer.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Active surveillance use for low-risk prostate cancer reaches 93% in VA System
2
FDA receives NDA submission for UGN-103 in recurrent LG-IR-NMIBC
3
Focal therapy for prostate cancer frequently used outside guideline-supported groups
4
Ryan Flannigan, MD, highlights phase 2 data on ST-01 for chronic scrotal content pain
5















